EUVIMEDEUVIMED entdecken
Kohortenstudie

Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study

Yeshong Park, Yeon Bi Han, Jinju Kim, MeeYoung Kang, Boram Lee, Eun Sung Ahn, Saemi Han, Haeryoung Kim, Hee-Young Na, Ho-Seong Han, Yoo-Seok Yoon

Pancreatology · 2024

DOI: 10.1016/j.pan.2024.03.013 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pancreatology, 2024. Verfasst von Yeshong Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplasm Recurrence, Local, Neoadjuvant Therapy, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Seoul National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although various pathological grading systems are available for evaluating the response of pancreatic ductal adenocarcinoma (PDAC) to neoadjuvant therapy (NAT), their prognostic value has not been thoroughly validated. This study examined whether microscopic tumor mapping of post-NAT specimens could predict tumor recurrence. METHODS: This prospective study enrolled 52 patients who underwent pancreaticoduodenectomy after NAT for PDAC between 2019 and 2021. Microscopic mapping was performed to identify residual tumor loci within the tumor bed using 4 mm2 pixels. Patients were divided into small extent (SE; n = 26) and large extent (LE; n = 26) groups using a cutoff value of 226 mm2. The diagnostic performance for predicting tumor recurrence was evaluated using receiver operating characteristic (ROC) curves. RESULTS: Carbohydrate antigen 19-9 levels were normalised after NAT in more patients in the SE group (SE 21 [80.8%] vs. LE 13 [50.0%]; P = 0.041). Tumor size (P < 0.001), T stage (P < 0.001), positive lymph node yield (P = 0.024), and perineural invasion rate (P = 0.018) were significantly greater in the LE group. The 3-year disease-free survival rate was significantly lower in the LE group (SE 83.3% vs. LE 50.0%, P = 0.004). The area under the ROC curve for mapping extent was 0.743, which was greater than that of the other tumor response scoring systems. CONCLUSIONS: Microscopic tumor mapping of the residual tumor in post-NAT specimens is a significant predictor of post-surgical recurrence, and offers better prognostic performance than the current grading systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoplasm Recurrence, LocalNeoadjuvant TherapyCarcinoma, Pancreatic DuctalPancreaticoduodenectomyHumansProspective StudiesMaleFemaleAgedMiddle AgedPrognosisCohort Studies

Stichwörter der Autor:innen

NATNeoadjuvant therapyPDACPancreatic cancerPancreatic ductal adenocarcinomaPancreatic surgeryTumor mapping

Autor:innen und Institutionen

  • Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea.
  • Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea.
  • Department of Pathology, Seoul National University Bundang Hospital, Republic of Korea.
  • Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Republic of Korea.
  • Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea. Electronic address: yoonys@snubh.org.

Förderung

  • Seoul National University

Zitieren

APA

Park, Y., Han, Y. B., Kim, J., Kang, M., Lee, B., Ahn, E. S., Han, S., Kim, H., Na, H. Y., Han, H. S., & Yoon, Y. S. (2024). Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study. Pancreatology. https://doi.org/10.1016/j.pan.2024.03.013

Vancouver

Park Y, Han YB, Kim J, Kang M, Lee B, Ahn ES, et al. Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study. Pancreatology. 2024. doi:10.1016/j.pan.2024.03.013

BibTeX
@article{Park2024,
  author = {Park, Yeshong and Han, Yeon Bi and Kim, Jinju and Kang, MeeYoung and Lee, Boram and Ahn, Eun Sung and Han, Saemi and Kim, Haeryoung and Na, Hee-Young and Han, Ho-Seong and Yoon, Yoo-Seok},
  title = {Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study},
  journal = {Pancreatology},
  year = {2024},
  doi = {10.1016/j.pan.2024.03.013}
}
Kostenlos starten →